Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Edith Zemanick

Concepts (221)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cystic Fibrosis
73
2025
1053
13.790
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
20
2025
312
5.130
Why?
Microbiota
13
2024
730
3.120
Why?
Pseudomonas Infections
12
2023
221
2.910
Why?
Anti-Bacterial Agents
24
2025
1717
2.770
Why?
Chloride Channel Agonists
9
2025
77
2.720
Why?
Pseudomonas aeruginosa
13
2023
347
2.650
Why?
Sweat
6
2025
46
2.620
Why?
Chlorides
4
2025
139
2.420
Why?
Quinolones
9
2024
126
2.290
Why?
Aminophenols
13
2025
144
2.150
Why?
Sputum
9
2021
302
2.040
Why?
Indoles
4
2024
387
1.620
Why?
Benzodioxoles
9
2024
105
1.580
Why?
Respiratory System
6
2021
154
1.450
Why?
Drug Combinations
7
2024
330
1.310
Why?
Oropharynx
3
2021
44
1.290
Why?
Specimen Handling
3
2021
164
1.200
Why?
Metagenome
4
2013
141
1.200
Why?
DNA, Bacterial
6
2019
324
1.180
Why?
Respiratory Tract Infections
5
2024
376
1.080
Why?
Lung
9
2023
3930
1.070
Why?
Inflammation
6
2017
2736
0.950
Why?
Pyrazoles
3
2024
405
0.930
Why?
Bronchoalveolar Lavage Fluid
7
2019
644
0.910
Why?
Anti-Infective Agents
2
2023
248
0.840
Why?
Child
37
2025
20883
0.790
Why?
Aspergillosis, Allergic Bronchopulmonary
1
2021
11
0.760
Why?
Humans
74
2025
129650
0.730
Why?
RNA, Ribosomal, 16S
5
2023
525
0.700
Why?
Microbial Sensitivity Tests
3
2021
352
0.670
Why?
Aminopyridines
4
2025
97
0.670
Why?
Drug Resistance, Bacterial
2
2021
176
0.640
Why?
Genetic Therapy
4
2023
292
0.550
Why?
Bacteria
8
2023
821
0.550
Why?
beta-Lactams
3
2023
28
0.540
Why?
Adolescent
24
2025
20393
0.530
Why?
Male
38
2025
63681
0.510
Why?
Nasopharynx
1
2016
67
0.490
Why?
Female
39
2025
68776
0.490
Why?
Respiratory Function Tests
5
2025
586
0.490
Why?
Carrier State
1
2016
60
0.490
Why?
Lung Diseases
3
2018
742
0.470
Why?
Bacteria, Anaerobic
2
2011
23
0.450
Why?
Vital Capacity
1
2014
291
0.430
Why?
Mutation
12
2023
3717
0.430
Why?
Saliva
1
2015
209
0.420
Why?
Respiratory Sounds
1
2014
118
0.420
Why?
Precision Medicine
1
2016
387
0.390
Why?
Bronchiectasis
1
2013
108
0.380
Why?
Age Factors
2
2025
3144
0.370
Why?
Genotype
3
2024
1839
0.370
Why?
Polymerase Chain Reaction
2
2011
1038
0.360
Why?
Pyridines
2
2024
478
0.350
Why?
Disease Progression
6
2025
2635
0.340
Why?
Disease Management
1
2014
589
0.330
Why?
Cytokines
2
2015
2017
0.320
Why?
Cardiovascular Diseases
1
2021
2004
0.310
Why?
Pneumonia, Bacterial
1
2009
115
0.300
Why?
Adult
15
2025
35576
0.300
Why?
Infant
7
2023
9024
0.290
Why?
Young Adult
11
2025
12426
0.280
Why?
Child, Preschool
11
2025
10517
0.280
Why?
Biofilms
2
2020
244
0.280
Why?
Clinical Trials as Topic
3
2024
1004
0.270
Why?
Quinolines
2
2024
156
0.260
Why?
Treatment Outcome
9
2025
10230
0.250
Why?
Meconium Ileus
1
2024
5
0.240
Why?
Oxygen
2
2020
915
0.230
Why?
Prospective Studies
7
2023
7133
0.230
Why?
Endpoint Determination
1
2024
76
0.210
Why?
Fetal Diseases
1
2024
158
0.210
Why?
Olfaction Disorders
1
2023
60
0.210
Why?
Central Venous Catheters
1
2023
48
0.200
Why?
Respiratory Syncytial Virus Infections
1
2024
120
0.200
Why?
Advisory Committees
1
2024
216
0.200
Why?
Catheter-Related Infections
1
2023
72
0.200
Why?
Methicillin-Resistant Staphylococcus aureus
2
2016
221
0.200
Why?
C-Reactive Protein
1
2025
401
0.200
Why?
Catheterization, Peripheral
1
2023
104
0.190
Why?
Aspergillus fumigatus
1
2021
23
0.190
Why?
Quality Improvement
3
2019
1103
0.190
Why?
Catheterization, Central Venous
1
2023
103
0.190
Why?
Trachea
1
2023
220
0.180
Why?
Antimicrobial Cationic Peptides
2
2019
77
0.180
Why?
Quality of Life
3
2023
2704
0.180
Why?
Tobramycin
3
2023
51
0.180
Why?
Venous Thrombosis
1
2023
176
0.180
Why?
Staphylococcal Infections
2
2016
393
0.180
Why?
Pseudomonas
2
2022
28
0.170
Why?
Respiratory System Agents
1
2020
22
0.160
Why?
Bacteriological Techniques
1
2019
69
0.160
Why?
Luminescent Measurements
1
2019
78
0.160
Why?
International Cooperation
1
2019
174
0.160
Why?
Bronchopulmonary Dysplasia
1
2024
378
0.150
Why?
Genetic Variation
2
2021
937
0.150
Why?
Critical Pathways
1
2019
80
0.150
Why?
Bacterial Infections
1
2020
237
0.150
Why?
Drug Prescriptions
1
2020
248
0.150
Why?
Delphi Technique
1
2019
225
0.150
Why?
Alleles
1
2021
845
0.150
Why?
Infant, Newborn
4
2024
5762
0.150
Why?
Aptamers, Nucleotide
1
2019
77
0.150
Why?
Immunoglobulin A
1
2019
200
0.140
Why?
United States
5
2024
13903
0.140
Why?
Gas Chromatography-Mass Spectrometry
1
2018
131
0.140
Why?
Nontuberculous Mycobacteria
1
2019
203
0.140
Why?
Safety
1
2019
331
0.140
Why?
Case-Control Studies
4
2019
3381
0.140
Why?
Blood Proteins
1
2019
242
0.140
Why?
Volatile Organic Compounds
1
2018
57
0.140
Why?
Pilot Projects
2
2023
1587
0.140
Why?
Membrane Transport Modulators
1
2017
8
0.140
Why?
Aldehyde Oxidoreductases
1
2017
27
0.140
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2016
37
0.130
Why?
Respiratory Mucosa
1
2019
307
0.130
Why?
Consensus
1
2019
616
0.130
Why?
Azithromycin
2
2023
93
0.130
Why?
Rifampin
1
2017
85
0.130
Why?
Foundations
1
2016
24
0.130
Why?
Cohort Studies
2
2017
5420
0.130
Why?
Patient Selection
1
2019
663
0.120
Why?
Longitudinal Studies
3
2021
2717
0.120
Why?
Cholesterol Esters
1
2015
7
0.120
Why?
Pulmonary Medicine
1
2016
79
0.120
Why?
Radiography
1
2017
798
0.120
Why?
Staphylococcus aureus
2
2018
438
0.120
Why?
Bronchi
1
2016
247
0.120
Why?
Regression Analysis
1
2017
993
0.120
Why?
Immunoglobulin G
1
2019
847
0.120
Why?
Double-Blind Method
1
2019
1876
0.120
Why?
Enterobacteriaceae
1
2015
39
0.120
Why?
Mycobacterium Infections, Nontuberculous
1
2019
352
0.120
Why?
Staphylococcus
1
2015
74
0.110
Why?
Enterobacteriaceae Infections
1
2015
41
0.110
Why?
Administration, Oral
3
2023
786
0.110
Why?
Achromobacter denitrificans
1
2014
1
0.110
Why?
Stenotrophomonas maltophilia
1
2014
2
0.110
Why?
Spirometry
1
2015
257
0.110
Why?
Genotyping Techniques
1
2014
72
0.110
Why?
Forced Expiratory Volume
3
2020
510
0.110
Why?
Retrospective Studies
4
2023
14518
0.110
Why?
Multivariate Analysis
1
2017
1502
0.110
Why?
Chronic Disease
1
2019
1720
0.110
Why?
Biomarkers
5
2020
3973
0.100
Why?
Genetic Markers
1
2014
338
0.100
Why?
DNA Mutational Analysis
1
2014
387
0.100
Why?
Leukocyte Elastase
1
2012
74
0.100
Why?
Proteomics
1
2019
1062
0.100
Why?
Animals
4
2019
35361
0.100
Why?
Feces
1
2015
440
0.090
Why?
Administration, Inhalation
2
2023
666
0.090
Why?
Sequence Analysis, DNA
1
2015
779
0.090
Why?
Proteolysis
1
2012
166
0.090
Why?
Middle Aged
4
2023
31154
0.090
Why?
DNA Barcoding, Taxonomic
1
2011
18
0.090
Why?
Biota
1
2011
35
0.090
Why?
Phenotype
1
2019
3076
0.090
Why?
Asthma
1
2024
2230
0.090
Why?
Neonatal Screening
1
2012
163
0.090
Why?
Intestinal Mucosa
1
2015
590
0.080
Why?
Risk Assessment
1
2019
3240
0.080
Why?
Morbidity
1
2009
302
0.080
Why?
Blood Glucose
1
2018
2097
0.070
Why?
Practice Guidelines as Topic
1
2016
1501
0.070
Why?
Pediatrics
1
2016
1052
0.070
Why?
Cross-Sectional Studies
2
2021
5066
0.070
Why?
Gastrointestinal Microbiome
1
2015
641
0.070
Why?
Follow-Up Studies
1
2014
4897
0.060
Why?
Pyrrolidines
1
2024
67
0.060
Why?
Dose-Response Relationship, Drug
2
2020
2012
0.060
Why?
Reproducibility of Results
1
2010
3083
0.050
Why?
Catheters, Indwelling
1
2023
80
0.050
Why?
Anaerobiosis
1
2021
57
0.050
Why?
Aged
1
2021
22103
0.050
Why?
Styrenes
1
2020
4
0.040
Why?
Colistin
1
2020
9
0.040
Why?
Porphyrins
1
2020
21
0.040
Why?
Pyridinium Compounds
1
2020
25
0.040
Why?
Dysbiosis
1
2021
169
0.040
Why?
Serologic Tests
1
2019
52
0.040
Why?
Diagnostic Tests, Routine
1
2019
102
0.040
Why?
Medical History Taking
1
2019
119
0.040
Why?
Immunity, Humoral
1
2019
118
0.040
Why?
Homozygote
1
2018
193
0.040
Why?
Symptom Assessment
1
2019
125
0.040
Why?
Cytochrome P-450 CYP3A Inducers
1
2017
5
0.030
Why?
Area Under Curve
1
2018
304
0.030
Why?
Glucose Tolerance Test
1
2018
356
0.030
Why?
Minocycline
1
2016
27
0.030
Why?
Biological Availability
1
2017
147
0.030
Why?
Chlorhexidine
1
2016
24
0.030
Why?
Severity of Illness Index
1
2025
2742
0.030
Why?
Biphenyl Compounds
1
2017
60
0.030
Why?
Anti-Infective Agents, Local
1
2016
42
0.030
Why?
ROC Curve
1
2018
503
0.030
Why?
Nanoparticles
1
2020
374
0.030
Why?
Drug Interactions
1
2017
394
0.030
Why?
Pharmacogenetics
1
2017
175
0.030
Why?
Drug Monitoring
1
2017
216
0.030
Why?
Capsule Endoscopes
1
2015
7
0.030
Why?
Telemedicine
1
2024
788
0.030
Why?
Leukocyte L1 Antigen Complex
1
2015
29
0.030
Why?
Permeability
1
2015
157
0.030
Why?
Autoimmunity
1
2019
862
0.030
Why?
Decision Making
1
2019
851
0.020
Why?
Liver Cirrhosis
1
2015
280
0.020
Why?
Genetic Carrier Screening
1
2012
26
0.020
Why?
Trypsinogen
1
2012
10
0.020
Why?
Blotting, Western
1
2015
1205
0.020
Why?
False Positive Reactions
1
2012
114
0.020
Why?
Pregnancy
1
2024
6402
0.020
Why?
DNA
1
2018
1400
0.020
Why?
Surveys and Questionnaires
1
2023
5406
0.020
Why?
Prognosis
1
2018
3794
0.020
Why?
Bacterial Proteins
1
2016
835
0.020
Why?
Proteins
1
2015
942
0.020
Why?
Genes, rRNA
1
2007
41
0.020
Why?
Genes, Bacterial
1
2007
157
0.020
Why?
Risk Factors
1
2019
9765
0.010
Why?
Molecular Sequence Data
1
2007
2832
0.010
Why?
Zemanick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)